XML 15 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Cost of uranium sales        
Operating expenses $ 568,033 $ 776,764 $ 1,886,157 $ 1,920,601
Accretion/amortization of asset retirement obligations 97,435 22,673 292,305 69,416
Depreciation and depletion 76,089 91,319 225,907 318,637
Impairment of uranium properties 769,580 296,628 1,449,235 1,048,400
Exploration expenses 282,478 12,402 1,033,838 69,861
Total cost of uranium sales 1,793,615 1,199,786 4,887,442 3,426,915
Loss from operations before corporate expenses (1,793,615) (1,199,786) (4,887,442) (3,426,915)
Corporate expenses:        
General and administrative 2,174,862 2,994,663 6,749,980 8,191,352
Depreciation 32,631 40,911 115,773 104,751
Total corporate expenses 2,207,493 3,035,574 6,865,753 8,296,103
Loss from operations (4,001,108) (4,235,360) (11,753,195) (11,723,018)
Other income and expense:        
Interest expense (3,859) (6,055) (253,485) (12,723)
Interest and other income, net 55,703 20,501 60,238 247,678
Net loss $ (3,949,264) $ (4,220,914) $ (11,946,442) $ (11,488,063)
Basic and diluted net loss per common share (in dollars per share) $ (0.20) $ (0.34) $ (0.63) $ (1.05)
Average weighted shares outstanding (in shares) 20,074,763 12,413,476 19,100,956 10,953,407